Emerging Nondopaminergic Medications for Parkinson’s Disease: Focusing on A(2A) Receptor Antagonists and GLP1 Receptor Agonists

Parkinson’s disease (PD) is a severe neurodegenerative disease characterized by classic motor features associated with the loss of dopaminergic neurons and appearance of Lewy bodies in the substantia nigra. Due to the complexity of PD, a definitive diagnosis in the early stages and effective managem...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Pei, Baker, Matthew, Banks, Samantha, Hong, Sa-Ik, Choi, Doo-Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Movement Disorder Society 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490190/
https://www.ncbi.nlm.nih.gov/pubmed/34399565
http://dx.doi.org/10.14802/jmd.21035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490190/
https://www.ncbi.nlm.nih.gov/pubmed/34399565
http://dx.doi.org/10.14802/jmd.21035

Ejemplares similares